M Burger1. 1. Klinik für Urologie Lehrstuhl der Universität Regensburg, Caritas-Krankenhaus St. Josef, Landshuter Str. 65, 93053, Regensburg, Deutschland. maximilian.burger@ukr.de.
Abstract
BACKGROUND: Metastasis is a common event in renal cell carcinoma. Surgical resection of metastases may be feasible in two scenarios: aiming at palliation, which may be feasible due to reduced radiosensitivity of renal cell cancer, and aiming at prolonging survival, which may be feasible given the rather good prognosis of some patterns of metastasis. OBJECTIVE: This review intends to reflect on current evidence for surgical resection of metastases in both scenarios. The literature was searched in PubMed and respective guidelines were reviewed. RESULTS AND CONCLUSIONS: Palliative resection is mainly feasible to control symptoms like spinal compression; adjuvant radiation is advisable. Resection is markedly feasible, however, for improvement of cancer-specific survival in probably all resectable patterns of metastasis-solitary, multiple, syn- and metachronous, and in all organs-provided complete resection can be achieved. A fairly good prognosis is seen in solitary pulmonary metastasis without concomitant hilar or mediastinal lymph node metastasis and a metachronous appearance following long recurrence-free survival after tumor nephrectomy; complete resection may be considered curative in certain cases. Neo- or adjuvant medical therapy or radiation is not established. In cases lacking complete resectability, stereotactic radiation may be considered as an alternative.
BACKGROUND: Metastasis is a common event in renal cell carcinoma. Surgical resection of metastases may be feasible in two scenarios: aiming at palliation, which may be feasible due to reduced radiosensitivity of renal cell cancer, and aiming at prolonging survival, which may be feasible given the rather good prognosis of some patterns of metastasis. OBJECTIVE: This review intends to reflect on current evidence for surgical resection of metastases in both scenarios. The literature was searched in PubMed and respective guidelines were reviewed. RESULTS AND CONCLUSIONS: Palliative resection is mainly feasible to control symptoms like spinal compression; adjuvant radiation is advisable. Resection is markedly feasible, however, for improvement of cancer-specific survival in probably all resectable patterns of metastasis-solitary, multiple, syn- and metachronous, and in all organs-provided complete resection can be achieved. A fairly good prognosis is seen in solitary pulmonary metastasis without concomitant hilar or mediastinal lymph node metastasis and a metachronous appearance following long recurrence-free survival after tumor nephrectomy; complete resection may be considered curative in certain cases. Neo- or adjuvant medical therapy or radiation is not established. In cases lacking complete resectability, stereotactic radiation may be considered as an alternative.
Authors: David W G Langerhuizen; Stein J Janssen; Quirine M J van der Vliet; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón Journal: J Surg Oncol Date: 2016-05-09 Impact factor: 3.454
Authors: Ioannis Hatzaras; Ana L Gleisner; Carlo Pulitano; Charbel Sandroussi; Kenzo Hirose; Omar Hyder; Christopher L Wolfgang; Luca Aldrighetti; Michael Crawford; Michael A Choti; Timothy M Pawlik Journal: HPB (Oxford) Date: 2012-05-31 Impact factor: 3.647
Authors: Daniel Y C Heng; J Connor Wells; Brian I Rini; Benoit Beuselinck; Jae-Lyun Lee; Jennifer J Knox; Georg A Bjarnason; Sumanta Kumar Pal; Christian K Kollmannsberger; Takeshi Yuasa; Sandy Srinivas; Frede Donskov; Aristotelis Bamias; Lori A Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun Young Rha; Jenny J Kim; Toni K Choueiri Journal: Eur Urol Date: 2014-06-13 Impact factor: 20.096
Authors: Sarah P Psutka; John C Cheville; Brian A Costello; Suzanne B Stewart-Merrill; Christine M Lohse; Bradley C Leibovich; Stephen A Boorjian; R Houston Thompson Journal: Urology Date: 2016-07-21 Impact factor: 2.649
Authors: Christopher D Jakubowski; Emily A Vertosick; Brian R Untch; Daniel Sjoberg; Elizabeth Wei; Frank L Palmer; Snehal G Patel; Robert J Downey; Vivian E Strong; Paul Russo Journal: J Surg Oncol Date: 2016-06-23 Impact factor: 3.454
Authors: Gert De Meerleer; Vincent Khoo; Bernard Escudier; Steven Joniau; Alberto Bossi; Piet Ost; Alberto Briganti; Valérie Fonteyne; Marco Van Vulpen; Nicolaas Lumen; Martin Spahn; Marc Mareel Journal: Lancet Oncol Date: 2014-04 Impact factor: 41.316